מאמרים עם הרשאות לגישה ציבורית - Stefan K Aligלמידע נוסף
לא זמינים באתר כלשהו: 2
MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS.
M Roschewski, DM Kurtz, J Westin, RC Lynch, SK Alig, C Macaulay, ...
Hematological Oncology 41, 2023
הרשאות: US National Institutes of Health
Distinct molecular determinants of treatment‐failure in elderly Hodgkin lymphoma identified by cell‐free DNA profiling: A LYSA Study.
C Rossi, JL Boegeholz, SK Alig, A Garofolo, MS Esfahani, ...
Hematological Oncology 41, 2023
הרשאות: US National Institutes of Health
זמינים באתר כלשהו: 24
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ...
Nature biotechnology 39 (12), 1537-1547, 2021
הרשאות: US National Institutes of Health, V Foundation, USA, Damon Runyon Cancer …
Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma
P Mondello, S Tadros, M Teater, L Fontan, AY Chang, N Jain, H Yang, ...
Cancer discovery 10 (3), 440-459, 2020
הרשאות: US National Institutes of Health
Inferring gene expression from cell-free DNA fragmentation profiles
MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ...
Nature biotechnology 40 (4), 585-597, 2022
הרשאות: US National Institutes of Health
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ...
Cancer cell 41 (1), 210-225. e5, 2023
הרשאות: US National Institutes of Health, Lymphoma Research Foundation, USA, V …
Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas
JA Mutter, SK Alig, MS Esfahani, EM Lauer, J Mitschke, DM Kurtz, J Kühn, ...
Journal of Clinical Oncology 41 (9), 1684-1694, 2023
הרשאות: US National Institutes of Health, German Research Foundation, Lymphoma …
Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma
D Bararia, JA Hildebrand, S Stolz, S Haebe, S Alig, CP Trevisani, ...
Cell reports 31 (5), 2020
הרשאות: German Research Foundation
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles
JC Hellmuth, A Louissaint Jr, M Szczepanowski, S Haebe, A Pastore, ...
Blood, The Journal of the American Society of Hematology 132 (16), 1695-1702, 2018
הרשאות: German Research Foundation
Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma
S Alig, CW Macaulay, DM Kurtz, U Dührsen, A Hüttmann, C Schmitz, ...
Journal of Clinical Oncology 39 (23), 2605-2616, 2021
הרשאות: US National Institutes of Health, Lymphoma Research Foundation, USA, Damon …
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma
RC Lynch, CS Ujjani, C Poh, EH Warren, SD Smith, M Shadman, B Till, ...
Blood, The Journal of the American Society of Hematology 141 (21), 2576-2586, 2023
הרשאות: US National Institutes of Health, Lymphoma Research Foundation, USA
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
SK Alig, M Shahrokh Esfahani, A Garofalo, MY Li, C Rossi, T Flerlage, ...
Nature 625 (7996), 778-787, 2024
הרשאות: US Department of Defense, US National Institutes of Health, Canadian …
ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression
HK Mannell, J Pircher, DI Chaudhry, SKC Alig, EG Koch, R Mettler, U Pohl, ...
Cardiovascular research 93 (1), 111-119, 2012
הרשאות: German Research Foundation
Impact of age on clinical risk scores in follicular lymphoma
S Alig, V Jurinovic, A Pastore, S Haebe, C Schmidt, AK Zoellner, ...
Blood Advances 3 (7), 1033-1038, 2019
הרשאות: US National Institutes of Health, German Research Foundation
Impact of age on genetics and treatment efficacy in follicular lymphoma
S Alig, V Jurinovic, A Pastore, D Bararia, S Häbe, JC Hellmuth, R Kridel, ...
Haematologica 103 (8), e364, 2018
הרשאות: US National Institutes of Health, German Research Foundation
The Endothelial Tyrosine Phosphatase SHP‐1 Plays an Important Role for Vascular Haemostasis in TNFα‐Induced Inflammation In Vivo
E Koch, J Pircher, T Czermak, E Gaitzsch, S Alig, H Mannell, M Niemeyer, ...
Mediators of inflammation 2013 (1), 279781, 2013
הרשאות: German Research Foundation
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel
L Sams, S Kruger, V Heinemann, D Bararia, S Haebe, S Alig, M Haas, ...
Clinical and Translational Oncology 23, 2394-2401, 2021
הרשאות: German Research Foundation, European Commission, Federal Ministry of …
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
HJJ Cherng, SK Alig, Y Oki, LJ Nastoupil, L Fayad, SS Neelapu, ...
Blood Advances 7 (7), 1137-1145, 2023
הרשאות: US National Institutes of Health
The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells
S Haebe, W Keay, S Alig, AW Mohr, LK Martin, M Heide, R Secci, S Krebs, ...
British journal of haematology 196 (6), 1381-1387, 2022
הרשאות: US National Institutes of Health, German Research Foundation, European …
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
P Johansson, S Alig, J Richter, C Hanoun, J Rekowski, J Dürig, B Ylstra, ...
Annals of Hematology 102 (12), 3445-3455, 2023
הרשאות: US National Institutes of Health
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב